# Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

> **NCT00557206** · PHASE2 · TERMINATED · sponsor: **Minneapolis Veterans Affairs Medical Center** · enrollment: 35 (actual)

## Conditions studied

- Neoplasms
- Head and Neck Neoplasms

## Interventions

- **DRUG:** Oxaliplatin and Docetaxel

## Key facts

- **NCT ID:** NCT00557206
- **Lead sponsor:** Minneapolis Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Funding was terminated
- **Last updated:** 2013-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557206, "Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00557206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*